The authors hypothesized that there was an association between amplification of HER2 and DLX4 in breast cancer since both HER2 and DLX4 genes are closely mapped on the long arm of human chromosome 17 but found no obvious gene co-amplification between the two. The gene discussed is DLX4; the disease is breast carcinoma.